ClearMains
Government proposes 30% trade-margin cap on patented and non-patented cancer medicines, but top court asks why a margin cap cannot be extended to all medicines and medical products; the court says the government has to ensure that DPCO-approved medicines, whose price is legally regulated, reach patients
Quick Revision
Prelims-testable facts
Trap alerts
Current-affairs link
The National Pharmaceutical Pricing Authority (NPPA) regulates the prices of essential medicines in India, and the Supreme Court's order may lead to changes in its regulations.
Prelims Practice MCQs
What percentage trade-margin cap has the Government proposed on patented and non-patented cancer medicines?
The Government has proposed a 30% trade-margin cap on patented and non-patented cancer medicines. This is a part of the Government's efforts to control the prices of essential medicines.
Consider the following statements regarding Trade Margin Cap on Essential Medicines: 1. The Government has proposed a 20% trade-margin cap on all essential medicines and medical products. 2. The Supreme Court has asked the Government to consider capping the trade margin for all essential medicines and medical products. 3. The Government has already implemented a 30% trade-margin cap on all essential medicines and medical products. How many of the above statements are correct?
Statement 1 is incorrect because the fact list only mentions a 30% trade-margin cap on patented and non-patented cancer medicines, not all essential medicines and medical products. Statement 2 is correct because the fact list states that the Supreme Court has asked the Government to consider capping the trade margin for all essential medicines and medical products. Statement 3 is incorrect because the fact list does not mention the implementation of a 30% trade-margin cap on all essential medicines and medical products.
Consider the following two statements: Statement-I: The Government has proposed a 30% trade-margin cap on patented and non-patented cancer medicines. Statement-II: The Supreme Court has asked the Government to consider capping the trade margin for all essential medicines and medical products because the Government has proposed a 30% trade-margin cap on patented and non-patented cancer medicines. Which one of the following is correct in respect of the above statements?
Statement 1 is correct because the fact list states that the Government has proposed a 30% trade-margin cap on patented and non-patented cancer medicines. Statement 2 is correct because the Supreme Court's request is a direct response to the Government's proposal to cap the trade margin for cancer medicines. Statement 2 explains why the Government is considering capping the trade margin for all essential medicines and medical products.